https://www.selleckchem.com/products/azd6738.html
Metabolic syndrome (MS) is recognized as a risk factor for colon cancer (CC). However, whether the cluster of metabolic changes that define MS also influence CC prognosis remains unclear. Thus, our aim was to investigate whether the presence of MS or any of the MS individual components could provide prognostic information on tumor phenotype and survival outcomes. Clinical and pathological data from patients with CC (n = 30 who underwent surgical resection at a single tertiary hospital were retrospectively collected to evaluate presenc
Curtir
Comentario
Compartilhar
